Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc. (FHTX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · FHTX · as of Sep 30, 2025
Ownership Breakdown
88
Institutional Holders
▲ 8 vs Q2
$200.24M
Total Inst. Value
▲ $7.69M vs Q2
58.71M
Shares Outstanding
freeFloat 46.68%
40.90M
13F Shares Held
▼ 66,177 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
FHTX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FLAGSHIP PIONEERING INC. pharmaceutical preparations | 12.67M | 20.12% | 20.12% | $61.98B | Nov 14, 2025 | — held |
FMR LLC pharmaceutical preparations | 5.47M | 8.69% | 8.69% | $26.77B | Nov 13, 2025 | ▼ 60.0K |
BVF INC/IL pharmaceutical preparations | 5.30M | 8.42% | 8.42% | $25.93B | Nov 14, 2025 | — held |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 3.26M | 5.17% | 5.17% | $15.92B | Nov 14, 2025 | — held |
RAYMOND JAMES FINANCIAL INC pharmaceutical preparations | 2.46M | 3.91% | 3.91% | $12.04B | Nov 14, 2025 | ▲ 95.2K |
BLACKROCK, INC. pharmaceutical preparations | 2.26M | 3.59% | 3.59% | $11.05B | Nov 12, 2025 | ▲ 30.8K |
VANGUARD GROUP INC pharmaceutical preparations | 1.90M | 3.02% | 3.02% | $9.29B | Nov 7, 2025 | ▲ 14.8K |
EUCLIDEAN CAPITAL LLC pharmaceutical preparations | 1.57M | 2.50% | 2.50% | $7.70B | Nov 14, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 808.5K | 1.28% | 1.28% | $3.95B | Nov 12, 2025 | ▲ 814 |
SIREN, L.L.C. pharmaceutical preparations | 720.7K | 1.14% | 1.14% | $3.52B | Nov 13, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
19
Increased
+632.4K shares4
New Positions
first time holders16
Decreased
−618.9K shares0
Sold Out
fully exitedNet shares change (top 50)
+13.5K
+632.4K / −618.9K
Net new holders
+7
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
FHTX insider trading · insider activity
Source: SEC Form 4
10
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
GOTTSCHALK ADRIAN Chief Executive Officer | Apr 10, 2026 | Gift | 59,208 | — | — | 270.9K | Form 4 ↗ |
GOTTSCHALK ADRIAN Chief Executive Officer | Apr 10, 2026 | Gift | 59,208 | — | — | 240.8K | Form 4 ↗ |
GOTTSCHALK ADRIAN Chief Executive Officer | Apr 9, 2026 | Gift | 47,497 | — | — | 211.7K | Form 4 ↗ |
GOTTSCHALK ADRIAN Chief Executive Officer | Apr 9, 2026 | Gift | 47,497 | — | — | 0 | Form 4 ↗ |
Maynard Ryan D Chief Financial Officer | Feb 23, 2026 | Award | 400,000 | $5.75 | $2.30M | 400.0K | Form 4 ↗ |
GOTTSCHALK ADRIAN Chief Executive Officer | Feb 5, 2026 | Award | 1,075,000 | $5.23 | $5.62M | 1.07M | Form 4 ↗ |
Costa Carlos Chief People Officer | Jan 30, 2026 | Award | 230,000 | $5.71 | $1.31M | 230.0K | Form 4 ↗ |
LaCascia Michael Chief Legal Officer | Jan 30, 2026 | Award | 295,000 | $5.71 | $1.68M | 295.0K | Form 4 ↗ |
Cardama Alfonso Quintas Chief Medical Officer | Jan 30, 2026 | Award | 300,000 | $5.71 | $1.71M | 300.0K | Form 4 ↗ |
Rivkin Anna Chief Business Officer | Jan 30, 2026 | Award | 165,000 | $5.71 | $942.1K | 165.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Foghorn Therapeutics Inc. (FHTX) is primarily owned by institutional investors, who hold approximately 69.7% of total shares outstanding. Company insiders own approximately 53.32%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Foghorn Therapeutics Inc. is FLAGSHIP PIONEERING INC., holding approximately 12.67 million shares — equal to 20.12% of outstanding shares — as of September 30, 2025.
A total of 88 institutional investors currently hold FHTX stock, with a combined institutional value of approximately $200,237,661 as of the most recent 13F filing period.
Frequently asked questions
FHTX ownershipFoghorn Therapeutics Inc. (FHTX) is primarily owned by institutional investors, who hold approximately 69.7% of shares. The largest shareholder is FLAGSHIP PIONEERING INC. with a 20.12% stake. Company insiders hold 53.32%. Data sourced from SEC Form 13F as of September 30, 2025.